Skip to main content
Figure 2 | Malaria Journal

Figure 2

From: Screening for an ivermectin slow-release formulation suitable for malaria vector control

Figure 2

Pharmacokinetic curves of the leading formulations. PK curves (median and range) of the four groups that maintained IVM levels of at least 10 ng/ml for the first 12 weeks and were selected to continue until week 25. The red triangle is the approximate PK curve of one single 150 μg/kg oral dose. The dotted line marks 7 ng/ml, the minimum LC50 determined in vivo for An. gambiae.

Back to article page